Andé, France

Philippe Muller

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 177(Granted Patents)


Location History:

  • And{acute over (e)}, FR (2001)
  • Ande, FR (2000 - 2019)
  • Andé, FR (2002 - 2023)

Company Filing History:


Years Active: 2000-2023

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Philippe Muller

Introduction

Philippe Muller, an innovative inventor based in Andé, France, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 17 patents, he has focused his efforts on developing novel compounds and solutions that address critical health challenges, particularly in the area of viral infections.

Latest Patents

Among his latest innovations are the macrocyclic deaza-purinones, which are derivatives designed for the treatment of viral infections. This invention encompasses processes for their preparation, pharmaceutical compositions, and their practical applications in treating various viral diseases. The dual focus on drug development and therapeutic application highlights Muller's commitment to advancing medical science.

Career Highlights

Throughout his distinguished career, Philippe Muller has worked with esteemed organizations, including Janssen Pharmaceutica NV and Janssen Sciences Ireland UC. His experience in these leading pharmaceutical companies has solidified his reputation as a prominent inventor in the industry, enabling him to contribute greatly to the development of innovative therapeutic solutions.

Collaborations

Muller has collaborated with several notable professionals in his field, including Frédéric Marc Maurice Doublet and Jean-François Bonfanti. These partnerships have fostered an environment of creativity and innovation, allowing for the exchange of ideas that drive forward-thinking research and development in pharmacology.

Conclusion

Philippe Muller's body of work exemplifies the impact that passionate inventors can have in the realm of medical advancements. His innovative approach to creating effective treatments for viral infections through macrocyclic deaza-purinones is a testament to his dedication to improving healthcare outcomes. As he continues to push the boundaries of science, his journey serves as an inspiration for aspiring inventors and innovators around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…